查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1332203

单核细胞激活测试的全球市场

Monocyte Activation Tests
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 244 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球单核细胞激活测试市场将达到 2980 万美元

在不断变化的后COVID-19商业环境中，单核细胞激活测试的全球市场预计2022年为1080万美元，到2030年市场规模将修正为2980万美元，2030年市场规模将达到2980万美元。预计2022 年至2030 年年复合成长率将达到 13.5%本报告分析的细分市场之一，单核细胞激活检测试剂盒，年复合成长率将达到 14.7%，预计到分析期结束时将达到 1630 万美元。鑑于大流行后的持续復苏，未来八年试剂细分市场的增长已调整为12.2%的年复合成长率。

美国市场预计为 330 万美元，中国预计复合年增长率为 12.9%

预计2022年美国单核细胞激活测试市场规模将达到330万美元。中国作为世界第二大经济体，预计到2030年市场规模将达到510万美元，2022年至2030年的分析期间年复合成长率为12.9%。其他值得注意的地域市场包括日本和加拿大，预计 2022 年至 2030 年将分别增长 12.1% 和 11.4%。在欧洲，德国的年复合成长率预计约为 9.7%。

受访企业示例

  • Becton, Dickinson & Company
  • Charles River Laboratories International, Inc.
  • Lonza Group AG
  • Merck KgaA
  • Microcoat Biotechnologie GmbH
  • Sanquin
  • Solvias AG
  • Thermo Fisher Scientific, Inc.

目录

第1章调查方法

第2章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和促进因素
  • 全球市场预测

第3章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 意大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 世界其他地区

第4章竞争

简介目录
Product Code: MCP16601

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Monocyte Activation Tests Market to Reach $29.8 Million by 2030

In the changed post COVID-19 business landscape, the global market for Monocyte Activation Tests estimated at US$10.8 Million in the year 2022, is projected to reach a revised size of US$29.8 Million by 2030, growing at aCAGR of 13.5% over the period 2022-2030. Monocyte Activation Test Kits, one of the segments analyzed in the report, is projected to record 14.7% CAGR and reach US$16.3 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Reagents segment is readjusted to a revised 12.2% CAGR for the next 8-year period.

The U.S. Market is Estimated at $3.3 Million, While China is Forecast to Grow at 12.9% CAGR

The Monocyte Activation Tests market in the U.S. is estimated at US$3.3 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.1 Million by the year 2030 trailing a CAGR of 12.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.1% and 11.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 9.7% CAGR.

Select Competitors (Total 41 Featured) -

  • Becton, Dickinson & Company
  • Charles River Laboratories International, Inc.
  • Lonza Group AG
  • Merck KgaA
  • Microcoat Biotechnologie GmbH
  • Sanquin
  • Solvias AG
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Monocyte Activation Tests - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Monocyte Activation Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 2: World 8-Year Perspective for Monocyte Activation Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Monocyte Activation Test Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 4: World 8-Year Perspective for Monocyte Activation Test Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 6: World 8-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Blood Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 8: World 8-Year Perspective for Blood Based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Peripheral Blood Mononuclear Cell (PBMC) Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 10: World 8-Year Perspective for Peripheral Blood Mononuclear Cell (PBMC) Based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Cell Line Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 12: World 8-Year Perspective for Cell Line Based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 14: World 8-Year Perspective for Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 16: World 8-Year Perspective for Biotechnology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 18: World 8-Year Perspective for Medical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Other End-Use Industries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 20: World 8-Year Perspective for Other End-Use Industries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 21: World Monocyte Activation Tests Market Analysis of Annual Sales in US$ for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Monocyte Activation Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 22: USA Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 23: USA 8-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2023 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 25: USA 8-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2023 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 27: USA 8-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2023 & 2030
  • CANADA
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 29: Canada 8-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2023 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 31: Canada 8-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2023 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 33: Canada 8-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2023 & 2030
  • JAPAN
    • Monocyte Activation Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 35: Japan 8-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2023 & 2030
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 37: Japan 8-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2023 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Japan 8-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2023 & 2030
  • CHINA
    • Monocyte Activation Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 40: China Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 41: China 8-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2023 & 2030
    • TABLE 42: China Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 43: China 8-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2023 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 45: China 8-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2023 & 2030
  • EUROPE
    • Monocyte Activation Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Monocyte Activation Tests by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 47: Europe 8-Year Perspective for Monocyte Activation Tests by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 49: Europe 8-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2023 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Europe 8-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2023 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 53: Europe 8-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2023 & 2030
  • FRANCE
    • Monocyte Activation Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 54: France Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 55: France 8-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2023 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 57: France 8-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2023 & 2030
    • TABLE 58: France Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 59: France 8-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2023 & 2030
  • GERMANY
    • Monocyte Activation Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 61: Germany 8-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2023 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Germany 8-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2023 & 2030
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 65: Germany 8-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2023 & 2030
  • ITALY
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 67: Italy 8-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2023 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Italy 8-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2023 & 2030
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 71: Italy 8-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2023 & 2030
  • UNITED KINGDOM
    • Monocyte Activation Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 72: UK Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 73: UK 8-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2023 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 75: UK 8-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2023 & 2030
    • TABLE 76: UK Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 77: UK 8-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2023 & 2030
  • REST OF EUROPE
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 8-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2023 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Rest of Europe 8-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2023 & 2030
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 8-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2023 & 2030
  • ASIA-PACIFIC
    • Monocyte Activation Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 8-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2023 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific 8-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2023 & 2030
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 8-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2023 & 2030
  • REST OF WORLD
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 91: Rest of World 8-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2023 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Rest of World 8-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2023 & 2030
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 95: Rest of World 8-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2023 & 2030

IV. COMPETITION